Top : For Professionals Only

CF Resources: For Professionals Only

Home | Add a Site | What's New | Email Updates | Random Link | Search

Categories:

Links:

  • A Child in Pain (1996) - This new book was written for parents, but is also relevant for health care providers of children in pain. The book provides an overview of children's perceptions of pain and general apsects of pain for different developmental stages. The second section discusses assessment and measurement of pain in children along with pharmacological and nonpharmacological approaches to the management of pain. A final section, designed for parents, includes common everyday childhood experiences with pain and fears about pain. Guidelines for each age group are presente (Added: 1-Dec-2002 Hits: 56 Rating: 0 ) Rate It
  • A laboratory studying Pseudomonas aeruginosa - The Hancock laboratory is engaged in three basic types of research; studies of the outer membrane proteins of Pseudomonas aeruginosa especially with respect to mechanisms of antibiotic uptake and resistance (permeability and efflux); cationic antimicrobial peptides ("nature's antibiotics") their role in innate immunity, development as novel antibiotics and mechanism of action; and, the functional genomics of Pseudomonas aeruginosa and innate immunity. (Added: 18-Sep-2002 Hits: 78 Rating: 0 ) Rate It
  • Antifungal--Sporanox (2002) - Sporanox (itraconazole capsules) is indicated for the treatment of pulmonary fungal infections in immunocompromised and non- immunocompromised patients (Added: 23-Oct-2002 Hits: 85 Rating: 0 ) Rate It
  • Atrovent (2002) - Ipratropium bromide inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. (Added: 23-Oct-2002 Hits: 59 Rating: 0 ) Rate It
  • Budesonide (entered 2002) - Budesonide Nasal Inhaler: Budesonide nasal inhaler is indicated for the management of symptoms of seasonal or perennial allergic rhinitis in adults and children and nonallergic perennial rhinitis in adults. (Added: 2-Dec-2002 Hits: 70 Rating: 0 ) Rate It
  • Caution: Trovan I.V. (1999) - In consultation with FDA, Pfizer has recently amended the prescribing information for TROVAN I.V. (alatrofloxacin mesylate injection) to include information on the potential incompatibility of alatrofloxacin mesylate injection with two commonly used diluents, 0.9% sodium chloride injection, USP (usually referred to as normal saline solution) and Lactated Ringer's, USP. (Added: 2-Dec-2002 Hits: 70 Rating: 0 ) Rate It
  • Chest X-Ray of a patient with CF--2001 - Cystic fibrosis. PA chest radiograph of a patient with cystic fibrosis. There is scarring, bronchial cuffing and bronchiectasis. Other photographs. (Added: 18-Sep-2002 Hits: 132 Rating: 0 ) Rate It
  • CM005: SYSTEMIC ANTI-INFLAMMATORY TREATMENT: NSAID (entered 2002) - The inflammatory response to chronic endobronchial infection, characterized by persistent neutrophil influx, contributes to lung destruction in cystic fibrosis (CF) (1). Attenuating the response with anti-inflammatory agents has been proposed as a therapeutic strategy. (Added: 2-Dec-2002 Hits: 61 Rating: 0 ) Rate It
  • CYSTIC FIBROSIS RESEARCH CENTER - Cystic Fibrosis (CF) Research Centers will foster multidisciplinary approaches to research ranging from elucidation of the molecular pathogenesis of CF to development of new therapies for this disorder. (Added: 17-Sep-2002 Hits: 39 Rating: 0 ) Rate It
  • Cystic-L Bookstore: Technical - If the book is available from Amazon.com a link is provided to read their review or order the book (note that clicking this link does not automatically order the book; it leads you to a page from which the book may be ordered if you so desire). (Added: 17-Dec-2002 Hits: 28 Rating: 0 ) Rate It
  • Diabetes - As the technology evolves which allows CF patients to live longer, new problems are cropping up. One of these is diabetes. About 30-50% of PWCF are reported to get glucose intolerance. (Added: 5-Dec-2002 Hits: 30 Rating: 0 ) Rate It

Next 20

Search

Looking for something in particular?
More search options

Pages Updated On: 27-Sep-2005 - 04:46:50
Links Engine 2.0 By: Gossamer Threads Inc.



Cystic Fibrosis-Reaching Out Foundation, Inc.
PO Box 870747
Stone Mountain, GA 30087
770-381-3710
770-564-2331 FAX
info@ReachingOutFoundation.org
www.ReachingOutFoundation.org

The Cystic Fibrosis-Reaching Out Foundation is a non-profit Foundation under Section 501 (c) 3 of the Internal Revenue Code. Accordingly, the Foundation is not required to pay income taxes. Donors may deduct contributions to the Cystic Fibrosis-Reaching Out Foundation Inc, only to the extent that their contributions are gifts, with no consideration given.